Literature DB >> 26126701

Evaluation of factors associated with vertical HIV-1 transmission.

Matheus Costa da Rosa1, Rubens Caurio Lobato1, Carla Vitola Gonçalves1, Naylê Maria Oliveira da Silva1, Maria Fernanda Martínez Barral1, Ana Maria Barral de Martinez1, Vanusa Pousada da Hora2.   

Abstract

OBJECTIVE: To compare the prevalence and factors associated with vertical transmission of human immunodeficiency virus 1 (HIV-1) among pregnant women treated in the periods of 1998-2004 and 2005-2011 in a reference service for the care of HIV-infected patients in southern Brazil.
METHODS: This was a descriptive and analytical study that used the databases of laboratories from the CD4 and STDs/AIDS Viral Load National Laboratory Network of the Brazilian Ministry of Health. HIV-1-infected pregnant women were selected after an active search for clinical information and obstetric and neonatal data from their medical records between the years of 1998 and 2011.
RESULTS: 102 pregnant women were analyzed between 1998 and 2004 and 251 in the period between 2005 and 2011, totaling 353 children born to pregnant women with HIV-1. It was observed that the vertical transmission rate was 11.8% between 1998 and 2004 and 3.2% between 2005 and 2011 (p<0.001). The increased use of antiretroviral drugs (p=0.02), the decrease in viral load (p<0.001), and time of membrane rupture lower than 4h (p<0.001) were associated with the decrease of vertical transmission factors when comparing the two periods.
CONCLUSION: It was observed a decrease in the rate of vertical transmission in recent years. According to the studied variables, is suggested that the risk factors for vertical transmission of HIV-1 were absence of antiretroviral therapy, high viral load in the pregnant women, and membrane rupture time >4h.
Copyright © 2015 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Grávidas; Human immunodeficiency virus type 1; Pregnant woman; Transmissão Vertical de Infecções; Vertical infection transmission; Vírus da Imunodeficiência Humana Tipo 1

Mesh:

Year:  2015        PMID: 26126701     DOI: 10.1016/j.jped.2014.12.005

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  4 in total

1.  Mother to child transmission of HIV in Brazil: Data from the "Birth in Brazil study", a national hospital-based study.

Authors:  Rosa Maria Soares Madeira Domingues; Valeria Saraceni; Maria do Carmo Leal
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

Review 2.  Review of the missed opportunities for the prevention of vertical transmission of HIV in Brazil.

Authors:  Mariana Fernandes Guimarães; Kathryn Lynn Lovero; Juliana Gregório de Avelar; Laís Lopes Pires; Giovanna Rodrigues Teixeira de Oliveira; Estela Magalhães Cosme; Camila de Morais Salviato; Thais Raquelly Dourado de Oliveira; Natália Beatriz Cabrera; Claudete Aparecida Araújo Cardoso
Journal:  Clinics (Sao Paulo)       Date:  2019-09-16       Impact factor: 2.898

3.  Retrospective analysis of risk factors and gaps in prevention strategies for mother-to-child HIV transmission in Rio de Janeiro, Brazil.

Authors:  Kathryn Lynn Lovero; Thais Raquelly Dourado de Oliveira; Estela Magalhães Cosme; Natália Beatriz Cabrera; Mariana Fernandes Guimarães; Juliana Gregório de Avelar; Giovanna Rodrigues Teixeira de Oliveira; Camila de Morais Salviato; Guillermo Douglass-Jaimes; Maria Leticia Santos Cruz; Esaú Custódio João; Ana Cláudia Mamede Wiering de Barros; Marcos Vinicius da Silva Pone; Ivete Martins Gomes; Lee Woodland Riley; Claudete Aparecida Araújo Cardoso
Journal:  BMC Public Health       Date:  2018-09-10       Impact factor: 3.295

4.  High vertical HIV transmission rate in the Midwest region of Brazil.

Authors:  Vanessa Terezinha Gubert de Matos; Fabiani de Morais Batista; Naiara Valera Versage; Clarice Souza Pinto; Vanessa Marcon de Oliveira; Érica Freire de Vasconcelos-Pereira; Roberta Barbeta Dos Rios de Matos; Márcia Maria Ferrairo Janini Dal Fabbro; Ana Lúcia Lyrio de Oliveira
Journal:  Braz J Infect Dis       Date:  2018-05-09       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.